Probiotic Use to Decrease the Incidence of Antibiotic Associated Diarrhea in Patients taking Systemic Antibiotics

Abstract

Antibiotic-associated diarrhea (AAD) affects many hospitalized patients that are prescribed broad spectrum antibiotics. Although AAD is not usually life threatening, 15-39% of cases are caused by Clostridium difficile. Clostridium difficile associated diarrhea (CDAD) can cause uncontrollable diarrhea, dehydration, skin breakdown, and even death. Research has shown that probiotics, live beneficial bacteria, administered alongside broad spectrum antibiotics can decrease the incidence of AAD and CDAD(Allen, 2013). From a nursing perspective, CDAD adds to hospital staff's workloads through the necessity of isolation precautions, soap-andwater handwashing, and frequent patient toileting. C. difficile ruleout is costly to hospitals due to required lab tests, isolation materials, private rooming, and increased length of stay. Additionally, patient satisfaction suffers as the physical barrier created between nurse and patient causes feelings of shame and perceptions that healthcare workers are distant and uncaring.